The strategic response by pharmaceutical firms to the medicaid most favored customer rules:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
1996
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
5717 |
| Schlagworte: | |
| Online-Zugang: | kostenfrei |
| Beschreibung: | 38 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011190566 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 970207s1996 xxu |||| 00||| eng d | ||
| 035 | |a (OCoLC)35686809 | ||
| 035 | |a (DE-599)BVBBV011190566 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-19 |a DE-521 | ||
| 050 | 0 | |a HB1 | |
| 100 | 1 | |a Scott Morton, Fiona |e Verfasser |0 (DE-588)124081320 |4 aut | |
| 245 | 1 | 0 | |a The strategic response by pharmaceutical firms to the medicaid most favored customer rules |c Fiona Scott Morton |
| 264 | 1 | |a Cambridge, Mass. |c 1996 | |
| 300 | |a 38 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 5717 | |
| 650 | 4 | |a Drugs |x Prices |z United States | |
| 650 | 4 | |a Medicaid |x Cost control | |
| 650 | 4 | |a Pharmaceutical industry |z United States |x Finance | |
| 651 | 4 | |a USA | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 5717 |w (DE-604)BV002801238 |9 5717 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w5717.pdf |z kostenfrei |3 Volltext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007505087 | ||
Datensatz im Suchindex
| _version_ | 1804125686758113280 |
|---|---|
| any_adam_object | |
| author | Scott Morton, Fiona |
| author_GND | (DE-588)124081320 |
| author_facet | Scott Morton, Fiona |
| author_role | aut |
| author_sort | Scott Morton, Fiona |
| author_variant | m f s mf mfs |
| building | Verbundindex |
| bvnumber | BV011190566 |
| callnumber-first | H - Social Science |
| callnumber-label | HB1 |
| callnumber-raw | HB1 |
| callnumber-search | HB1 |
| callnumber-sort | HB 11 |
| callnumber-subject | HB - Economic Theory and Demography |
| ctrlnum | (OCoLC)35686809 (DE-599)BVBBV011190566 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01310nam a2200361 cb4500</leader><controlfield tag="001">BV011190566</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970207s1996 xxu |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)35686809</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011190566</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-521</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Scott Morton, Fiona</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)124081320</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The strategic response by pharmaceutical firms to the medicaid most favored customer rules</subfield><subfield code="c">Fiona Scott Morton</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">38 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">5717</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Prices</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicaid</subfield><subfield code="x">Cost control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">United States</subfield><subfield code="x">Finance</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">5717</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">5717</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w5717.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007505087</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV011190566 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:05:30Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007505087 |
| oclc_num | 35686809 |
| open_access_boolean | 1 |
| owner | DE-19 DE-BY-UBM DE-521 |
| owner_facet | DE-19 DE-BY-UBM DE-521 |
| physical | 38 S. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Scott Morton, Fiona Verfasser (DE-588)124081320 aut The strategic response by pharmaceutical firms to the medicaid most favored customer rules Fiona Scott Morton Cambridge, Mass. 1996 38 S. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 5717 Drugs Prices United States Medicaid Cost control Pharmaceutical industry United States Finance USA Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 5717 (DE-604)BV002801238 5717 http://papers.nber.org/papers/w5717.pdf kostenfrei Volltext |
| spellingShingle | Scott Morton, Fiona The strategic response by pharmaceutical firms to the medicaid most favored customer rules National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Drugs Prices United States Medicaid Cost control Pharmaceutical industry United States Finance |
| title | The strategic response by pharmaceutical firms to the medicaid most favored customer rules |
| title_auth | The strategic response by pharmaceutical firms to the medicaid most favored customer rules |
| title_exact_search | The strategic response by pharmaceutical firms to the medicaid most favored customer rules |
| title_full | The strategic response by pharmaceutical firms to the medicaid most favored customer rules Fiona Scott Morton |
| title_fullStr | The strategic response by pharmaceutical firms to the medicaid most favored customer rules Fiona Scott Morton |
| title_full_unstemmed | The strategic response by pharmaceutical firms to the medicaid most favored customer rules Fiona Scott Morton |
| title_short | The strategic response by pharmaceutical firms to the medicaid most favored customer rules |
| title_sort | the strategic response by pharmaceutical firms to the medicaid most favored customer rules |
| topic | Drugs Prices United States Medicaid Cost control Pharmaceutical industry United States Finance |
| topic_facet | Drugs Prices United States Medicaid Cost control Pharmaceutical industry United States Finance USA |
| url | http://papers.nber.org/papers/w5717.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT scottmortonfiona thestrategicresponsebypharmaceuticalfirmstothemedicaidmostfavoredcustomerrules |